Regeneron Pharmaceuticals
REGN
#217
Rank
S$111.65 B
Marketcap
$1,016
Share price
-3.28%
Change (1 day)
-5.01%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): S$6.58 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$13.84 Billion. In 2023 the company made an earning of S$5.63 Billion a decrease over its 2022 earnings that were of S$6.52 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$6.58 B16.74%
2023 S$5.63 B-13.57%
2022 S$6.52 B-47.9%
2021 S$12.52 B144.75%
2020 S$5.11 B56.86%
2019 S$3.26 B-4.87%
2018 S$3.42 B22.86%
2017 S$2.79 B56.3%
2016 S$1.78 B8.55%
2015 S$1.64 B54.53%
2014 S$1.06 B11.14%
2013 S$0.95 B72.13%
2012 S$0.55 B-285.93%
2011 -S$0.3 Billion121.73%
2010 -S$0.14 Billion37.18%
2009 -S$98.39 Million-14.6%
2008 -S$0.12 Billion-25.02%
2007 -S$0.16 Billion6.32%
2006 -S$0.15 Billion-186.52%
2005 S$0.16 B2103.7%
2004 S$7.58 M-105.66%
2003 -S$0.14 Billion-18.18%
2002 -S$0.17 Billion42.33%
2001 -S$0.12 Billion129.35%
2000 -S$50.16 Million51.87%
1999 -S$33.03 Million92.19%
1998 -S$17.19 Million66.23%
1997 -S$10.34 Million-55.49%
1996 -S$23.23 Million103.53%
1995 -S$11.42 Million-70.89%
1994 -S$39.21 Million-26.08%
1993 -S$53.04 Million114.67%
1992 -S$24.71 Million196.77%
1991 -S$8.33 Million87.88%
1990 -S$4.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$6.28 B-5.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.26 Billion-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.76 B-73.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.69 B 270.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.09 B 156.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$9.94 B 49.07%๐Ÿ‡ซ๐Ÿ‡ท France